Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 13, 2026
Bitmine Immersion Technologies (BMNR): Could Shares Reach +34% Toward the $24 Level?

Bitmine Immersion Technologies (BMNR): Could Shares Reach +34% Toward the $24 Level?

Key Takeaways

  • The selected stock price target is $24, about 34% above BMNR's recent close near $17.89.
  • $24 sits just below the lowest current Wall Street 12-month analyst target of $25 and near a widely discussed $23–$24 resistance zone.
  • The strongest bullish factors are Bitmine's massive Ethereum treasury, growing staking revenue, and Russell 1000 inclusion.
  • The biggest risks are direct exposure to Ethereum price swings, steep reported losses, share dilution, and extreme volatility.
  • Key technical levels are support at $13–$14 and resistance at $17.50–$18; a decisive breakout above $18 would open the path toward $23–$24.
  • For investors, $24 is ambitious but not disconnected from analyst models; it would likely require a sustained Ethereum rally, not just a short-term bounce.

Why the $24 Target Draws Attention

BMNR's 52-week range of $12.80 to $71.74 shows how sharply the stock has moved. A push to $24 would deliver meaningful upside from the recent close without needing a return to the prior peak. That positions the level as a practical checkpoint rather than an unrealistic stretch.

The target also aligns with the broader analyst picture. According to MarketBeat, the consensus 12-month analyst price target sits near $27.65, with a range from $25 to $30.30. S&P Global data points to an average near $31.87. In short, $24 sits on the conservative side of published Wall Street estimates, which gives the discussion added weight.

BMNR as an Ethereum Treasury Vehicle

Although Bitmine started as a Bitcoin mining and immersion-cooling operation, it now positions itself primarily as an Ethereum treasury company. Its “alchemy of 5%” approach aims for ownership of 5% of Ethereum’s circulating supply. By late July 2026, the company reported holding roughly 5.79 million ETH, plus Bitcoin, cash, and equity stakes, bringing total disclosed crypto and cash holdings to about $11.8 billion.

That figure is relevant because BMNR’s market capitalization has recently hovered near $10.8 billion, so the shares have traded at a modest discount to the stated value of holdings. The stock effectively functions in part as a leveraged play on Ethereum rather than solely as an operating business.

Bitmine has also developed a staking operation via its MAVAN validator network. Staking and validation revenue reached $45.7 million in the fiscal third quarter, representing about 98% of total revenue and roughly four times the prior quarter. Management has guided for annualized staking revenue between $211 million and $246 million, depending on deployment scale.

Potential Drivers Toward $24

The clearest catalyst remains a sustained increase in Ethereum’s price. Analysts at Cantor Fitzgerald and B. Riley have noted that near-term upside depends primarily on Ethereum appreciation rather than operational gains alone. Because BMNR holds millions of ETH, a higher token price directly lifts the value of the treasury and can support the stock.

Staking execution is the next key factor. Continued growth in staking revenue, paired with evidence that the platform can cover preferred-stock obligations, could shift valuation toward recurring cash flow instead of pure token-price beta.

Index inclusion provides an additional structural boost. Bitmine joined the Russell 1000 Index in late June 2026, which management and market observers have tied to greater passive-fund demand and wider institutional ownership.

Technical momentum also plays a role. Market commentary has flagged $17.50–$18 as a critical resistance zone. A decisive close above $18 could reframe the narrative from recovery to breakout, bringing the $23–$24 area into focus. Short interest near 8% of the float could amplify any upside move through forced covering.

Obstacles That Could Limit the Advance

The bear case centers on BMNR’s high correlation to Ethereum. If ETH weakens, treasury value declines, the discount could persist or widen, and the recovery thesis stalls. The company has also posted steep quarterly losses, including a recent $128.25 per share loss on $46.53 million in revenue, illustrating how digital-asset accounting can distort reported results.

Dilution remains another headwind. Preferred-stock issuance and an increased share count affect per-share metrics and can pressure the common equity. Weiss Ratings has kept a sell rating, reflecting ongoing skepticism about the fundamental profile.

From a technical standpoint, failure to clear $18 would likely keep the stock rangebound, while a break below the $13–$14 support zone could trigger a retest of the 52-week low and push the $24 target further out of reach.

Key Technical Levels to Watch

The most important support level sits in the $13–$14 zone, where the stock has stabilized after prior selling pressure. Holding above $14 is necessary to maintain the recovery structure.

The most important resistance level is $17.50–$18. This area previously acted as support before the correction and now represents the hurdle bulls must reclaim. Beyond that zone, the next major supply area is $23–$24, combining a psychological round number with prior chart resistance.

Monitoring BMNR with Tickeron Tools

I also checked this setup using Tickeron’s AI tools to see how the patterns compare across the sector. The platform’s AI-driven signals help track evolving conditions without reviewing every chart manually.

AI Daily Buy/Sell Signals

In my own research process, I frequently reference AI Daily Buy/Sell Signals from Tickeron when following names like BMNR. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals drawn from market behavior, technical patterns, and AI analysis. It serves as a practical way to spot shifts, track positions, and identify changing trends alongside other research steps.

Final Assessment

A move toward $24 looks plausible yet conditional. The target sits below most published analyst price targets, and the stock has recently traded near or below the stated value of its crypto holdings. The main supporting elements remain Ethereum price strength, expanding staking revenue, passive inflows from Russell 1000 inclusion, and a technical breakout above $18.

The risks are equally straightforward: Ethereum exposure cuts both ways, reported losses and dilution complicate the fundamentals, and the $18 resistance remains unbroken. Investors should track Ethereum’s trend, quarterly staking revenue, share-count changes, and whether BMNR can hold the $13–$14 support while testing the $17.50–$18 resistance zone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BMNR

BMNR's RSI Indicator leaves overbought zone

The 10-day RSI Indicator for BMNR moved out of overbought territory on September 01, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 instances where the indicator moved out of the overbought zone. In 14 of the 14 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 68 of 77 cases where BMNR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMNR as a result. In 120 of 131 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for BMNR turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 65 similar instances when the indicator turned negative. In 59 of the 65 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMNR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

BMNR broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +3.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMNR advanced for three days, in 94 of 136 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 66 of 89 cases where BMNR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. BMNR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.302) is normal, around the industry mean (4.522). P/E Ratio (0.000) is within average values for comparable stocks, (21.199). BMNR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.559). Dividend Yield (0.000) settles around the average of (0.031) among similar stocks. BMNR's P/S Ratio (144.928) is very high in comparison to the industry average of (17.303).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.57B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -4%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 3%. BRR experienced the highest price growth at 17%, while LGHL experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was 19% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 64
Price Growth Rating: 54
SMR Rating: 74
Profit Risk Rating: 85
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
BMNR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Profile
Details
Industry
N/A
Address
10845 Griffith Peak
Phone
+1 404 816-8240
Employees
7
Web
https://www.bitminetech.io
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.